Physician profile
Steven Hughes
NPI 1255349148
$89,325.06
in general payments reported to CMS, 2019-2025
6 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,767 · 2021: $7,235 · 2022: $21K · 2023: $13K · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $55K · Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $55,122.15 |
| Food and Beverage | $145.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $83,926.63 | 2019-2025 | Viacell / Trifecta, Versatie, Victory |
| Arteriocyte Medical Systems, INC. | $5,174.96 | 2019-2021 | |
| Boston Scientific Corporation | $89.40 | 2023-2024 | Eluvia, Peripheral Rotalink Plus |
| Medtronic, INC. | $62.62 | 2022 | |
| Supreme Orthopedic Systems, LLC | $55.74 | 2025 | |
| Horizon Therapeutics Plc | $15.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.